The symposium offers an overview of current knowledge and clinical practice in transgender health, with a broad focus on mental and physical health in transgender and gender diverse populations. Participants will receive an update on gender-affirming hormone treatment, including recommendations based on current national and international treatment guidelines and recent research.

Through presentations by invited speakers, participants will gain insight into the latest evidence on health outcomes, risk factors, and long-term follow-up in transgender and gender diverse populations including considerations for gender affirming hormone therapy, monitoring, and the prevention and management of mental and physical morbidity.

The program aims to offer a platform for scientific exchange, feedback, and networking across disciplines and institutions.

Submit an abstract to present your work during the poster pitches (see “Abstract Instructions”). Abstracts are optional, but those who submit an abstract are given priority. All registrants start on a waiting list and will be notified of their status after the abstract deadline.

Confirmed speakers

• Astrid Højgaard, Chief Physician, Klinisk Lektor, Centre for Sexology, Aalborg University Hospital, Denmark 
• Guy T’Sjoen, Professor, Department of Endocrinology, Ghent, Belgium
• Marco Vecciato, MD, University of Padua, Italy 
• Mette Elmose, Head of Unit and Associate Professor, University of Southern Denmark, Denmark
• Mette Tranberg Nielsen, Associate Professor, Department of Clinical Medicine – Aarhus University, Denmark 
• Zoltan Barkanyi, Head of Department, Consultant in Charge of Psychotherapy, Odense University Hospital, Denmark
• Jack Graesser, Medical Student, University of Southern Denmark, Denmark 

Organisers:

• Dorte Glintborg, Professor, Department of Endocrinology, Odense University Hospital, Odense, Denmark. 
• Louise Lehmann Christensen, Klinisk Lektor, Department of Endocrinology, Odense University Hospital, Odense, Denmark. 
• Tine Taulbjerg Kristensen, Postdoc, Head of Clinic and Head of Psychology, Department of Endocrinology, Odense University Hospital, Odense, Denmark. 
• Camilla Viola Buskbjerg Palm, Specialist Physician, Postdoc, Department of Gynaecology, Odense University Hospital, Odense, Denmark. 

This symposium is intended for clinicians and researchers working within the field of transgender health.

Abstract submission is optional, but participants who submit an abstract will be given priority. All registrations will initially be placed on a waiting list, and applicants will be notified of their participation status after the abstract submission deadline.

Please note that you are not guaranteed a seat if you do not meet the target group requirements. If the event is overbooked, the DDEA reserves its right to select participants based on the defined requirements.

Dinner registration:
A networking dinner will be held on March 15th. Participation is free of charge — please sign up for the dinner upon registration and indicate any dietary requirements.

Accommodation:
Signing up for the events includes meals and drinks and networking dinner with costs covered by DDEA.     

Accommodation is not included as part of the event and should be organized by the participants individually. 

Latest cancellation date & no-show fee

Latest cancellation is March 1st 2027. Please note that it is free of charge to participate in the event, however the organisers will charge a no-show fee of 1000 DKK if you do not show up and have not unregistered from the event.

Format of Abstract:

Deadline for submission of abstracts:  
3/01-2027

Abstract submission is optional, but participants who submit an abstract will be given priority. All registrations will initially be placed on a waiting list, and applicants will be notified of their participation status after the abstract submission deadline.

Abstract guidelines:
Be sure your abstract contains the following information and adheres to the following formatting guidelines before submission:

You may download the template here

The abstract should be max 1500 characters incl. spaces and written in Arial 10.

• Title of abstract (Use a short and specific title with title-style capitalization and put it in bold)

• Presenting author name(s) (Underline the presenting author’s name)

• Affiliation (Include unit, institution/company/hospital, city and country for all authors and put it in italic)
  

The body of the abstract contains the following content: background and aim, rationale, methods, results (if obtained to-date), conclusion (and perspectives)
(Text in Arial 10)

No images, figures, charts or tables should be included in the abstract.

Please proofread carefully before submission and submit a Word file and please name the file that you submit with your name. 

Format of poster:

Size of poster: A0 or A1 – width max. 1m/height max. 1.25 m (“Portrait format” is visually preferred)